You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (34) |
Back to Search
Ezetimibe-mediated prevention and recovery of hepatic NPC1L1-dependent dietary steatosis in mice.
- At: PSWC2020 (2020)
- Type: Poster
- By: TAKADA, Tappei (The University of Tokyo Hospital, Department of Pharmacy, Japan)
- Co-author(s): Tappei Takada: Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan
Yu Toyoda: Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan
Yoshihide Yamanashi: Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan
Hiroshi Suzuki: Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan - Abstract:
Background
Non-alcoholic fatty liver disease (NAFLD) is a serious global public health concern. Nevertheless, there are no specific medications for treating the associated abnormal accumulation of hepatic lipids such as cholesterol and triglycerides. While seminal findings suggest a link between hepatic cholesterol accumulation and NAFLD.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026